Note: Ingredients listed on restricted chemical lists
General Information
Version
4.1 en
Revision date
2019-10-21
Product name
Psoralen ROTICHROM HPLC
Product Synonyms
7-H-Furo[3,2-g]benzopyran-7-one
CAS No.
66-97-7
REACH No
It
Icons in SDS
Company Information
company name
Carl Roth GmbH + Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
Hazard categories
Cat- Hazard class and egory
Hazard statements
3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation 2 Eye Irrit. 2 H319 3.8R Specific target organ toxicity - single exposure (respir- STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16 2.2 Label elements Labelling according to Regulation (EC) No 1272/2008 (CLP) Signal word Warning Pictograms GHS07 Hazard statements H315 Causes skin irritation H319 Causes serious eye irritation H335 May cause respiratory irritation Precautionary statements Precautionary statements - prevention P261 Avoid breathing dust P280 Wear protective gloves/protective clothing/eye protection/face protection/hear- ing protection Precautionary statements - response P302+P352 IF ON SKIN: Wash with plenty of water P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P312 Call a POISON CENTRE/doctor if you feel unwell Labelling of packages where the contents do not exceed 125 ml Signal word: Warning Hazard pictogram(s): H335 May cause respiratory irritation. P261 Avoid breathing dust. P312 Call a POISON CENTRE/doctor if you feel unwell. Labelling of packages where the contents do not exceed 10 ml Signal word: Not required Hazard pictogram(s): Not required Hazard statements: Not required Precautionary statements: Not required 2.3 Other hazards Results of PBT and vPvB assessment According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.